Want to see NHP full AI Analyst Report?
Top Page
National Healthcare Properties
(NASDAQ:NHP)
Select Model
Select Model
Rating:45Neutral
Price Target:
$16.50
▼(-1.96% Downside)
Action:N/A
Date:06/17/26
The score is weighed down primarily by weak financial performance (ongoing losses, negative free cash flow, elevated leverage, and a sharp 2025 revenue contraction). Technicals add modest pressure with the price below the 20-day average and low RSI/stochastic. Valuation is constrained by negative earnings (negative P/E) and no dividend yield data.
Positive Factors
Improving operating profitability
EBIT turning slightly positive and recovering EBITDA margins indicate the business is finding operational leverage and cost discipline. If sustained, these improvements support durable earnings power and capacity to cover fixed obligations typical for healthcare REITs, aiding long-term stability.
Negative Factors
Elevated leverage
High absolute debt and a ~1.7x debt-to-equity ratio constrain financial flexibility and raise refinancing and interest rate risk. For a REIT with volatile cash flow, elevated leverage increases the chance of covenant pressure and limits capacity for acquisitions or opportunistic investments.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving operating profitability
EBIT turning slightly positive and recovering EBITDA margins indicate the business is finding operational leverage and cost discipline. If sustained, these improvements support durable earnings power and capacity to cover fixed obligations typical for healthcare REITs, aiding long-term stability.
Read all positive factors
National Healthcare Properties (NHP) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$362.17M
Dividend Yield0.48%
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)-0.48
Revenue Growth-2.13%
EPS Growth51.61%
CountryUS
Employees31
SectorReal Estate
Sector Strength53
IndustryREIT - Healthcare Facilities
Share Statistics
EPS (TTM)-2.60
Shares Outstanding44,275,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)0.57
Price to Sales (P/S)0.99
P/FCF Ratio-15.60
Enterprise Value/Market Cap3.36
Enterprise Value/Revenue3.55
Enterprise Value/Gross Profit9.46
Enterprise Value/Ebitda16.53
Forecast
1Y Price Target
$17.43Price Target Upside3.56% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)0.16
Revenue Forecast (FY)$356.33M
National Healthcare Properties Business Overview & Revenue Model
Company Description
National Healthcare Properties, Inc. (NHP) operates as a real estate investment trust (REIT), concentrating its efforts on acquiring, owning, and overseeing a varied portfolio of properties within the healthcare industry. The company's activities ...
How the Company Makes Money
null...
National Healthcare Properties Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
44
Neutral
Cash Flow
34
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 342.12M | 342.28M | 353.79M | 345.93M |
| Gross Profit | 128.49M | 123.38M | 132.34M | 128.13M |
| EBITDA | 73.51M | 82.02M | -36.49M | 76.87M |
| Net Income | -60.36M | -57.62M | -189.70M | -72.30M |
Balance Sheet | ||||
| Total Assets | 1.70B | 1.71B | 1.95B | 2.15B |
| Cash, Cash Equivalents and Short-Term Investments | 106.60M | 57.62M | 21.65M | 46.41M |
| Total Debt | 1.05B | 1.05B | 1.15B | 1.18B |
| Total Liabilities | 1.10B | 1.11B | 1.26B | 1.24B |
| Stockholders Equity | 592.16M | 600.06M | 684.56M | 894.15M |
Cash Flow | ||||
| Free Cash Flow | 8.87M | -21.77M | -101.75M | -773.00K |
| Operating Cash Flow | 37.19M | 6.95M | -79.85M | 21.62M |
| Investing Cash Flow | -13.66M | 69.81M | 63.97M | -62.82M |
| Financing Cash Flow | -43.35M | -42.40M | -1.35M | 55.97M |
National Healthcare Properties Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $15.34B | 17.52 | 16.92% | 5.18% | 15.18% | 72.69% | |
72 Outperform | $3.72B | 24.65 | 9.88% | 4.57% | 16.91% | -1.91% | |
66 Neutral | $2.06B | 15.60 | 11.79% | 5.41% | 48.96% | 28.05% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | $523.15M | 162.04 | 4.96% | 10.14% | 5.24% | ― | |
57 Neutral | $602.48M | 31.01 | 12.79% | 6.80% | 0.75% | 7.29% | |
45 Neutral | $362.17M | -5.88 | -9.79% | 0.48% | -2.13% | 51.61% |
* Real Estate Sector Average
NHP
National Healthcare Properties
16.83
4.89
40.93%
LTC
LTC Properties
39.45
5.76
17.10%
NHI
National Health Investors
75.38
3.89
5.44%
OHI
Omega Healthcare
48.68
11.01
29.24%
CHCT
Community Healthcare
15.58
2.37
17.92%
UHT
Universal Health Realty Income
42.07
6.15
17.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.